Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
02
08
2023
received:
13
03
2023
accepted:
04
08
2023
medline:
20
9
2023
pubmed:
31
8
2023
entrez:
31
8
2023
Statut:
ppublish
Résumé
Myeloid neoplasms may metastasize to the skin, presenting a wide range of clinical-pathological features that often lead to a reduction in patients' survival. The presentation varies depending on the category of myeloid neoplasm and its prognostic significance. The literature has specifically focused on the features of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and chronic myelomonocytic leukemia (CMML). In this article, we aimed to uncover the peculiarities of clonal skin proliferations in the course of Ph-negative myeloproliferative neoplasms (MPNs). We conducted a systematic review and statistical analysis of the literature data. MPN patients mainly exhibited cutaneous extramedullary hematopoiesis, while a minority displayed cutaneous histiocytic lesions. Furthermore, these patients showed lower survival rates compared to the median survival of MPN patients, especially when calculating survival from the appearance of cutaneous lesions. Our work highlights, for the first time, the prognostic relevance and histological heterogeneity of cutaneous lesions in MPN. Moreover, it emphasizes the importance of dermatological and histological examinations when cutaneous lesions are present.
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1228-1236Informations de copyright
© 2023 the International Society of Dermatology.
Références
Solans M, Sanvisens A, Ameijide A, Merino S, Rojas D, Alemán A, et al. Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries. Sci Rep. 2022;12(1):323. https://doi.org/10.1038/s41598-021-03734-6
Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200-1228. https://doi.org/10.1182/blood.2022015850
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703-1719. https://doi.org/10.1038/s41375-022-01613-1
Maglie R, Genovese G, Solimani F, Guglielmo A, Pileri A, Portelli F, et al. Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review. Am J Clin Dermatol. 2020;21(6):833-854. https://doi.org/10.1007/s40257-020-00553-9
Li AW, Yin ES, Stahl M, Kim TK, Panse G, Zeidan AM, et al. The skin as a window to the blood: cutaneous manifestations of myeloid malignancies. Blood Rev. 2017;31(6):370-388. https://doi.org/10.1016/j.blre.2017.07.003
Fraga GR, Caughron SK. Cutaneous myelofibrosis with JAK2 V617F mutation: metastasis, not merely extramedullary hematopoiesis! Am J Dermatopathol. 2010;32(7):727-730. https://doi.org/10.1097/DAD.0b013e3181d3ca2f
Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol. 1999;40(6):966-978. https://doi.org/10.1016/S0190-9622(99)70086-1
Vitte F, Fabiani B, Bénet C, Dalac S, Balme B, Delattre C, et al. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol. 2012;36(9):1302-1316. https://doi.org/10.1097/PAS.0b013e31825dd4de
Magro CM, Momtahen S, Nguyen GH, Wang X. Histiocytoid Sweet's Syndrome: a localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease. Eur J Dermatol. 2015;25(4):335-341. https://doi.org/10.1684/ejd.2015.2586
Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, et al. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. J Am Acad Dermatol. 2014;70(6):1021-1027. https://doi.org/10.1016/j.jaad.2014.01.874
Alegría-Landa V, Rodríguez-Pinilla SM, Santos-Briz A, Rodríguez-Peralto JL, Alegre V, Cerroni L, et al. Clinicopathologic, immunohistochemical, and molecular features of histiocytoid sweet syndrome. JAMA Dermatol. 2017;153(7):651-659. https://doi.org/10.1001/jamadermatol.2016.6092
Magro CM, Kiani B, Li J, Crowson AN. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease. J Cutan Pathol. 2007;34(7):526-534. https://doi.org/10.1111/j.1600-0560.2006.00654.x
Teyateeti P, Ungtrakul T. Retrospective review of cutaneous metastasis among 11,418 patients with solid malignancy: a tertiary cancer center experience. Medicine (Baltimore). 2021;100(29):e26737. https://doi.org/10.1097/MD.0000000000026737
Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004;31(6):419-430. https://doi.org/10.1111/j.0303-6987.2004.00207.x
Mathew RA, Bennett JM, Liu JJ, Komrokji RS, Lancet JE, Naghashpour M, et al. Cutaneous manifestations in CMML: indication of disease acceleration or transformation to AML and review of the literature. Leuk Res. 2012;36(1):72-80. https://doi.org/10.1016/j.leukres.2011.05.003
Wang CX, Pusic I, Anadkat MJ. Association of leukemia cutis with survival in acute myeloid leukemia. JAMA Dermatol. 2019;155(7):826-832. https://doi.org/10.1001/jamadermatol.2019.0052
Yook HJ, Son JH, Kim YH, Han JH, Lee JH, Park YM, et al. Leukaemia cutis: clinical features and outcomes of 56 patients. Acta Derm Venereol. 2022;102:adv00647. https://doi.org/10.2340/actadv.v102.1123
Bonometti A, Gliozzo J, Moltrasio C, Bagnoli F, Berti E. Cutaneous-group histiocytoses associated with myeloid malignancies: a systematic review of 102 cases. Australas J Dermatol. 2021;62(2):e162-e169. https://doi.org/10.1111/ajd.13491
Miyata T, Masuzawa M, Katsuoka K, Higashihara M. Cutaneous extramedullary hematopoiesis in a patient with idiopathic myelofibrosis. J Dermatol. 2008;35(7):456-461. https://doi.org/10.1111/j.1346-8138.2008.00502.x
Hickling RA. Chronic non-leukaemic myelosis1. QJM. 1937;6(3):253-275. https://doi.org/10.1093/oxfordjournals.qjmed.a068284
Lieberman PH, Rosvoll RV, Ley AB. Extramedullary myeloid tumors in primary myelofibrosis. Cancer. 1965;18:727-736. https://doi.org/10.1002/1097-0142(196506)18:6<727::aid-cncr2820180610>3.0.co;2-8
Kuo T, Uhlemann J, Reinhard EH. Cutaneous extramedullary hematopoiesis. Arch Dermatol. 1976;112(9):1302-1303.
Ortonne JP, Jeune R, Perrot H. Myeloid metaplasia of the skin in two patients suffering from primary myelofibrosis. Arch Dermatol. 1977;113(10):1459.
Tagami H, Tashima M, Uehara N. Myelofibrosis with skin lesions. Br J Dermatol. 1980;102(1):109-112. https://doi.org/10.1111/j.1365-2133.1980.tb05677.x
Kuo T. Cutaneous extramedullary hematopoiesis presenting as leg ulcers. J Am Acad Dermatol. 1981;4(5):592-596. https://doi.org/10.1016/s0190-9622(81)70062-8
Sarma DP. Extramedullary hemopoiesis of the skin. Arch Dermatol. 1981;117(1):58-59.
Beckman EN, Oehrle JS. Fibrous hematopoietic tumors arising in agnogenic myeloid metaplasia. Hum Pathol. 1982;13(9):804-810. https://doi.org/10.1016/s0046-8177(82)80076-2
Hocking WG, Lazar GS, Lipsett JA, Busuttil RW. Cutaneous extramedullary hematopoiesis following splenectomy for idiopathic myelofibrosis. Am J Med. 1984;76(5):956-958. https://doi.org/10.1016/0002-9343(84)91023-4
Levine LE, Pearson MG, Baron JM, Medenica MM, Vardiman J. Extramedullary hematopoiesis. Arch Dermatol. 1984;120(10):1282.
Green LK, Klima M, Burns TR. Extramedullary hematopoiesis occurring in a hemangioma of the skin. Arch Dermatol. 1988;124(11):1720-1721.
Pedro-Botet J, Feliu E, Rozman C, Agustí C, Ribera JM, Bladé J, et al. Cutaneous myeloid metaplasia with dysplastic features in idiopathic myelofibrosis. Int J Dermatol. 1988;27(3):179-180. https://doi.org/10.1111/j.1365-4362.1988.tb04926.x
Puig L, Pilar García M, de Moragas JM, Matias Guiu X, Moreno A, Cadafalch J. Cutaneous extramedullary hematopoiesis in a patient with acute myelofibrosis. Arch Dermatol. 1988;124(3):329-331. https://doi.org/10.1001/archderm.124.3.329
Mizoguchi M, Kawa Y, Minami T, Nakayama H, Mizoguchi H. Cutaneous extramedullary hematopoiesis in myelofibrosis. J Am Acad Dermatol. 1990;22(2 Pt 2):351-355. https://doi.org/10.1016/0190-9622(90)70046-k
Schofield JK, Shun JL, Cerio R, Grice K. Cutaneous extramedullary hematopoiesis with a preponderance of atypical megakaryocytes in myelofibrosis. J Am Acad Dermatol. 1990;22(2 Pt 2):334-337. https://doi.org/10.1016/0190-9622(90)70041-f
Albeda FW, van der Meer J, Vellenga E. Vascular proliferation as an unusual cause of hemorrhagic diathesis in myelofibrosis. Am J Clin Pathol. 1991;95(4):564-566. https://doi.org/10.1093/ajcp/95.4.564
Hoss DM, McNutt NS. Cutaneous myelofibrosis. J Cutan Pathol. 1992;19(3):221-225. https://doi.org/10.1111/j.1600-0560.1992.tb01663.x
Loewy G, Mathew A, Distenfeld A. Skin manifestation of agnogenic myeloid metaplasia. Am J Hematol. 1994;45(2):167-170. https://doi.org/10.1002/ajh.2830450213
Patel BM, Su WP, Perniciaro C, Gertz MA. Cutaneous extramedullary hematopoiesis. J Am Acad Dermatol. 1995;32(5 Pt 1):805-807. https://doi.org/10.1016/0190-9622(95)91480-3
Ruberto E, Espinola R, Brusco J, Bacchiocchi M, Zoppi J, Paz R. Idiopathic myelofibrosis with extramedullary hematopoiesis foci in the skin and testicles. Report of a case. Sangre (Barc). 1995;40(2):157-160.
Kwon KS, Lee JB, Jang HS, Chung TA, Oh CK. A case of cutaneous extramedullary hematopoiesis in myelofibrosis with a preponderance of eosinophilic precursor cells. J Dermatol. 1999;26(6):379-384. https://doi.org/10.1111/j.1346-8138.1999.tb03493.x
Revenga F, Hörndler C, Aguilar C, Paricio JF. Cutaneous extramedullary hematopoiesis. Int J Dermatol. 2000;39(12):957-958. https://doi.org/10.1046/j.1365-4362.2000.00008-5.x
Cox NH, West NC, Popple AW. Multicentric reticulohistiocytosis associated with idiopathic myelofibrosis. Br J Dermatol. 2001;145(6):1033-1034. https://doi.org/10.1046/j.1365-2133.2001.04483.x
Shome D, Al-Ajami A, Sharif S, Jamsheer H, Malik A. Agnogenic myeloid metaplasia with cutaneous granulocytic sarcomas. Bahrain Med Bull. 1991;23. https://www.bahrainmedicalbulletin.com/june_2001/Agnogenic.pdf
Tanaka M, Kanamori H, Yamaji S, Mishima A, Yamazaki E, Taguchi J, et al. Subcutaneous extramedullary hematopoiesis in a patient with secondary myelofibrosis following polycythemia vera. Leuk Lymphoma. 2001;40(3-4):437-440. https://doi.org/10.3109/10428190109057946
Rogalski C, Paasch U, Friedrich T, Haustein UF, Sticherling M. Cutaneous extramedullary hematopoiesis in idiopathic myelofibrosis. Int J Dermatol. 2002;41(12):883-884. https://doi.org/10.1046/j.1365-4362.2002.01635.x
Fernández Aceñero MJ, Borbujo J, Villanueva C, Peñalver J. Extramedullary hematopoiesis in an adult. J Am Acad Dermatol. 2003;48(5 Suppl):S62-S63. https://doi.org/10.1067/mjd.2003.267
Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78(10):1223-1233. https://doi.org/10.4065/78.10.1223
Paolini R, Bonaldi L, Bianchini E, Ramazzina E, Cella G. Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukaemia with trisomy 8, trisomy 21 and cutaneous involvement. Eur J Haematol. 2003;71(6):466-469. https://doi.org/10.1046/j.0902-4441.2003.00139.x
Haniffa MA, Wilkins BS, Blasdale C, Simpson NB. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders. J Am Acad Dermatol. 2006;55(2 Suppl):S28-S31. https://doi.org/10.1016/j.jaad.2005.11.1038
Corella F, Barnadas MA, Bordes R, Curell R, Espinosa Í, Vergara C, et al. A case of cutaneous extramedullary hematopoiesis associated with idiopathic myelofibrosis. Actas Dermosifiliogr. 2008;99(4):297-300.
Collie AMB, Uchin JM, Bergfeld WF, Billings SD. Cutaneous intravascular extramedullary hematopoiesis in a patient with post-polycythemia vera myelofibrosis. J Cutan Pathol. 2013;40(7):615-620. https://doi.org/10.1111/cup.12178
Pecci A, Croci G, Balduini CL, Boveri E. Cutaneous involvement by post-polycythemia vera myelofibrosis. Am J Hematol. 2014;89(4):448. https://doi.org/10.1002/ajh.23539
Konca Degertekin C, Ozkurt ZN, Akyürek N, Yağcı M. A rare presentation of extramedullary hematopoiesis in post-polycythemic myelofibrosis. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):12-16. https://doi.org/10.1007/s12288-012-0218-z
LeBlanc RE, Lester L, Kwong B, Rieger KE. JAK2-positive cutaneous myelofibrosis presenting as sclerosing extramedullary hematopoietic tumors on the scalp: case presentation and review of the literature. J Cutan Pathol. 2015;42(11):858-862. https://doi.org/10.1111/cup.12553
Bonometti A, Bagnoli F, Fanoni D, Venegoni L, Corti L, Bianchi P, et al. JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib. Hum Pathol. 2018;73:171-175. https://doi.org/10.1016/j.humpath.2017.10.017
Kogame T, Hirata M, Kataoka TR, Seidel JA, Ueshima C, Matsui M, et al. Presence of SCF/CXCL12 double-positive large blast-like cells at the site of cutaneous extramedullary haematopoiesis. J Eur Acad Dermatol Venereol. 2018;32(12):e465-e466. https://doi.org/10.1111/jdv.15068
Holst JM, Enemark MB, Plesner TL, Pedersen MB, Ludvigsen M, d'Amore F. Coexisting BRAF-mutated langerhans cell histiocytosis and primary myelofibrosis with shared JAK2 mutation. Case Rep Hematol. 2021;2021:6623706. https://doi.org/10.1155/2021/6623706
Isei M, Nakata J, Deno R, Sugihara F, Matsuura A, Shibano M, et al. Langerhans cell histiocytosis associated with primary myelofibrosis presenting as disseminated maculopapular rash. J Dermatol. 2023;50:e133-e134. https://doi.org/10.1111/1346-8138.16671
Saleh J, Regmi A, Speiser JJ, Mudaliar KM, Omman R, Velankar M, et al. A case of primary myelofibrosis with transformation to leukemia cutis. Am J Dermatopathol. 2022;44(1):58-61. https://doi.org/10.1097/DAD.0000000000001999
Hickling R. A. Chronic non-leukaemic myelosis. Accessed January 9, 2023. https://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1937&pages=253&journal=Quart+J+Med&issue=%00null%00&issn=%00null%00&author=RA+Hickling&title=Chronic+non%E2%80%90leukemic+myelosis&pmid=%00empty%00&doi=%00null%00
Gianelli U, Fiori S, Cattaneo D, Bossi A, Cortinovis I, Bonometti A, et al. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients. Histopathology. 2017;71(6):897-908. https://doi.org/10.1111/his.13309
Bonometti A, Borsani O, Rumi E, Ferretti VV, Dioli C, Lucato E, et al. Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver. Cancer Med. 2022;12:7815-7822. https://doi.org/10.1002/cam4.5542
Khalil S, Ariel Gru A, Saavedra AP. Cutaneous extramedullary haematopoiesis: implications in human disease and treatment. Exp Dermatol. 2019;28(11):1201-1209. https://doi.org/10.1111/exd.14013
Hu SCS, Chen GS, Wu CS, Chai CY, Chen WT, Lan CCE. Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol. 2009;60(3):379-387. https://doi.org/10.1016/j.jaad.2008.10.007
Schulman JM, Pauli ML, Neuhaus IM, Sanchez Rodriguez R, Taravati K, Shin US, et al. The distribution of cutaneous metastases correlates with local immunologic milieu. J Am Acad Dermatol. 2016;74(3):470-476. https://doi.org/10.1016/j.jaad.2015.10.012
Soppi E, Nousiainen T, Seppa A, Lahtinen R. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature. Br J Haematol. 1989;73(1):43-47. https://doi.org/10.1111/j.1365-2141.1989.tb00217.x
Vignon-Pennamen MD, Juillard C, Rybojad M, Wallach D, Daniel MT, Morel P, et al. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Arch Dermatol. 2006;142(9):1170-1176. https://doi.org/10.1001/archderm.142.9.1170
Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2021;96(1):145-162. https://doi.org/10.1002/ajh.26050
Bonometti A, Berti E, for Associazione Italiana Ricerca Istiocitosi ONLUS. Reticulohistiocytoses: a revision of the full spectrum. J Eur Acad Dermatol Venereol. 2020;34(8):1684-1694. https://doi.org/10.1111/jdv.16214
Fusco N, Bonometti A, Augello C, Fabris S, Boiocchi L, Fiori S, et al. Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia. Histopathology. 2017;70(6):1000-1008. https://doi.org/10.1111/his.13166
Zanella S, Berti E, Bonometti A, for Associazione Italiana Ricerca Istiocitosi ONLUS. Indeterminate cell histiocytosis: a systematic review of the literature with a comprehensive revision of clinical, histopathological, and molecular features. J Eur Acad Dermatol Venereol. 2023;37(8):1559-1575. https://doi.org/10.1111/jdv.19095
Klaeschen AS, Nümm TJ, Herrmann N, Leib N, Maintz L, Sakai T, et al. JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis. J Allergy Clin Immunol. 2021;147(6):2202-2212.e8. https://doi.org/10.1016/j.jaci.2020.11.041
Heine A, Held SAE, Daecke SN, Wallner S, Yajnanarayana SP, Kurts C, et al. The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood. 2013;122(7):1192-1202. https://doi.org/10.1182/blood-2013-03-484642
Rudolph J, Heine A, Quast T, Kolanus W, Trebicka J, Brossart P, et al. The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK. Leukemia. 2016;30(10):2119-2123. https://doi.org/10.1038/leu.2016.155
Jayavelu AK, Schnöder TM, Perner F, Herzog C, Meiler A, Krishnamoorthy G, et al. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature. 2020;588(7836):157-163. https://doi.org/10.1038/s41586-020-2968-3
Cozzani E, Iurlo A, Merlo G, Cattaneo D, Burlando M, Pierri I, et al. Essential thrombocythemia: the dermatologic point of view. Clin Lymphoma Myeloma Leuk. 2015;15(12):739-747. https://doi.org/10.1016/j.clml.2015.08.086
Jackson N, Burt D, Crocker J, Boughton B. Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus. Br J Dermatol. 1987;116(1):21-29. https://doi.org/10.1111/j.1365-2133.1987.tb05787.x
Gavini DR, Salvi DJ, Shah PH, Uma D, Lee JH, Hamid P. Non-melanoma skin cancers in patients on hydroxyurea for philadelphia chromosome-negative myeloproliferative neoplasms: a systematic review. Cureus. 2021;13(8):e16978. https://doi.org/10.7759/cureus.16978